Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1177 to 1185 of 1185 entries
Sorted by: Best Match Show Resources per page
Considerations for treatment duration in responders to immune checkpoint inhibitors.

Journal for immunotherapy of cancer

Marron TU, Ryan AE, Reddy SM, Kaczanowska S, Younis RH, Thakkar D, Zhang J, Bartkowiak T, Howard R, Anderson KG, Olson D, Naqash AR, Patel RB, Sachdev E, Rodriguez-Ruiz ME, Sheffer M, Church S, Fuhrman C, Overacre-Delgoffe A, Nguyen R, Florou V, Thaxton JE, Aggen DH, Guerriero JL.
PMID: 33653801
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001901.

Immune checkpoint inhibitors (ICIs) have improved overall survival for cancer patients, however, optimal duration of ICI therapy has yet to be defined. Given ICIs were first used to treat patients with metastatic melanoma, a condition that at the time...

Cite
Marron TU, Ryan AE, Reddy SM, et al. Considerations for treatment duration in responders to immune checkpoint inhibitors. J Immunother Cancer. 2021;9(3)doi: 10.1136/jitc-2020-001901.
Marron, T. U., Ryan, A. E., Reddy, S. M., Kaczanowska, S., Younis, R. H., Thakkar, D., Zhang, J., Bartkowiak, T., Howard, R., Anderson, K. G., Olson, D., Naqash, A. R., Patel, R. B., Sachdev, E., Rodriguez-Ruiz, M. E., Sheffer, M., Church, S., Fuhrman, C., Overacre-Delgoffe, A., Nguyen, R., Florou, V., Thaxton, J. E., Aggen, D. H., & Guerriero, J. L. (2021). Considerations for treatment duration in responders to immune checkpoint inhibitors. Journal for immunotherapy of cancer, 9(3), . https://doi.org/10.1136/jitc-2020-001901
Marron, Thomas U, et al. "Considerations for treatment duration in responders to immune checkpoint inhibitors." Journal for immunotherapy of cancer vol. 9,3 (2021). doi: https://doi.org/10.1136/jitc-2020-001901
Marron TU, Ryan AE, Reddy SM, Kaczanowska S, Younis RH, Thakkar D, Zhang J, Bartkowiak T, Howard R, Anderson KG, Olson D, Naqash AR, Patel RB, Sachdev E, Rodriguez-Ruiz ME, Sheffer M, Church S, Fuhrman C, Overacre-Delgoffe A, Nguyen R, Florou V, Thaxton JE, Aggen DH, Guerriero JL. Considerations for treatment duration in responders to immune checkpoint inhibitors. J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001901. PMID: 33653801; PMCID: PMC7929825.
Copy Download .nbib Format: NLM
COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment - Meeting report from an isirv-WHO virtual conference.

Antiviral research

McKimm-Breschkin JL, Hay AJ, Cao B, Cox RJ, Dunning J, Moen AC, Olson D, Pizzorno A, Hayden FG.
PMID: 34933044
Antiviral Res. 2022 Jan;197:105227. doi: 10.1016/j.antiviral.2021.105227. Epub 2021 Dec 18.

The International Society for Influenza and other Respiratory Virus Diseases (isirv) and the WHO held a joint virtual conference from 19th-21st October 2021. While there was a major focus on the global response to the SARS-CoV-2 pandemic, including antivirals,...

Cite
McKimm-Breschkin JL, Hay AJ, Cao B, et al. COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment - Meeting report from an isirv-WHO virtual conference. Antiviral Res. 2021;197:105227doi: 10.1016/j.antiviral.2021.105227.
McKimm-Breschkin, J. L., Hay, A. J., Cao, B., Cox, R. J., Dunning, J., Moen, A. C., Olson, D., Pizzorno, A., & Hayden, F. G. (2022). COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment - Meeting report from an isirv-WHO virtual conference. Antiviral research, 197105227. https://doi.org/10.1016/j.antiviral.2021.105227
McKimm-Breschkin, Jennifer L, et al. "COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment - Meeting report from an isirv-WHO virtual conference." Antiviral research vol. 197 (2022): 105227. doi: https://doi.org/10.1016/j.antiviral.2021.105227
McKimm-Breschkin JL, Hay AJ, Cao B, Cox RJ, Dunning J, Moen AC, Olson D, Pizzorno A, Hayden FG. COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment - Meeting report from an isirv-WHO virtual conference. Antiviral Res. 2022 Jan;197:105227. doi: 10.1016/j.antiviral.2021.105227. Epub 2021 Dec 18. PMID: 34933044; PMCID: PMC8684224.
Copy Download .nbib Format: NLM
Reference Case Methods for Expert Elicitation in Health Care Decision Making.

Medical decision making : an international journal of the Society for Medical Decision Making

Bojke L, Soares MO, Claxton K, Colson A, Fox A, Jackson C, Jankovic D, Morton A, Sharples LD, Taylor A.
PMID: 34271832
Med Decis Making. 2021 Jul 16;272989X211028236. doi: 10.1177/0272989X211028236. Epub 2021 Jul 16.

BACKGROUND: The evidence used to inform health care decision making (HCDM) is typically uncertain. In these situations, the experience of experts is essential to help decision makers reach a decision. Structured expert elicitation (referred to as elicitation) is a...

Cite
Bojke L, Soares MO, Claxton K, et al. Reference Case Methods for Expert Elicitation in Health Care Decision Making. Med Decis Making. 2021;272989X211028236doi: 10.1177/0272989X211028236.
Bojke, L., Soares, M. O., Claxton, K., Colson, A., Fox, A., Jackson, C., Jankovic, D., Morton, A., Sharples, L. D., & Taylor, A. (2021). Reference Case Methods for Expert Elicitation in Health Care Decision Making. Medical decision making : an international journal of the Society for Medical Decision Making, 272989X211028236. https://doi.org/10.1177/0272989X211028236
Bojke, Laura, et al. "Reference Case Methods for Expert Elicitation in Health Care Decision Making." Medical decision making : an international journal of the Society for Medical Decision Making vol. (2021): 272989X211028236. doi: https://doi.org/10.1177/0272989X211028236
Bojke L, Soares MO, Claxton K, Colson A, Fox A, Jackson C, Jankovic D, Morton A, Sharples LD, Taylor A. Reference Case Methods for Expert Elicitation in Health Care Decision Making. Med Decis Making. 2021 Jul 16;272989X211028236. doi: 10.1177/0272989X211028236. Epub 2021 Jul 16. PMID: 34271832.
Copy Download .nbib Format: NLM
Breast mass segmentation in ultrasound with selective kernel U-Net convolutional neural network.

Biomedical signal processing and control

Byra M, Jarosik P, Szubert A, Galperin M, Ojeda-Fournier H, Olson L, O'Boyle M, Comstock C, Andre M.
PMID: 34703489
Biomed Signal Process Control. 2020 Aug;61. doi: 10.1016/j.bspc.2020.102027. Epub 2020 Jun 26.

In this work, we propose a deep learning method for breast mass segmentation in ultrasound (US). Variations in breast mass size and image characteristics make the automatic segmentation difficult. To address this issue, we developed a selective kernel (SK)...

Cite
Byra M, Jarosik P, Szubert A, et al. Breast mass segmentation in ultrasound with selective kernel U-Net convolutional neural network. Biomed Signal Process Control. 2020;61doi: 10.1016/j.bspc.2020.102027.
Byra, M., Jarosik, P., Szubert, A., Galperin, M., Ojeda-Fournier, H., Olson, L., O'Boyle, M., Comstock, C., & Andre, M. (2020). Breast mass segmentation in ultrasound with selective kernel U-Net convolutional neural network. Biomedical signal processing and control, 61. https://doi.org/10.1016/j.bspc.2020.102027
Byra, Michal, et al. "Breast mass segmentation in ultrasound with selective kernel U-Net convolutional neural network." Biomedical signal processing and control vol. 61 (2020). doi: https://doi.org/10.1016/j.bspc.2020.102027
Byra M, Jarosik P, Szubert A, Galperin M, Ojeda-Fournier H, Olson L, O'Boyle M, Comstock C, Andre M. Breast mass segmentation in ultrasound with selective kernel U-Net convolutional neural network. Biomed Signal Process Control. 2020 Aug;61. doi: 10.1016/j.bspc.2020.102027. Epub 2020 Jun 26. PMID: 34703489; PMCID: PMC8545275.
Copy Download .nbib Format: NLM
Addressing Hidden Curricula that Subvert the Patient-Centeredness "Hub" of the Pharmacists' Patient Care Process "Wheel".

American journal of pharmaceutical education

Olson AW, Isetts BJ, Stratton TP, Vaidyanathan R, Hager KD, Schommer JC.
PMID: 34301574
Am J Pharm Educ. 2021 Jul 22;8665. doi: 10.5688/ajpe8665. Epub 2021 Jul 22.

No abstract available.

Cite
Olson AW, Isetts BJ, Stratton TP, et al. Addressing Hidden Curricula that Subvert the Patient-Centeredness "Hub" of the Pharmacists' Patient Care Process "Wheel". Am J Pharm Educ. 2021;8665doi: 10.5688/ajpe8665.
Olson, A. W., Isetts, B. J., Stratton, T. P., Vaidyanathan, R., Hager, K. D., & Schommer, J. C. (2021). Addressing Hidden Curricula that Subvert the Patient-Centeredness "Hub" of the Pharmacists' Patient Care Process "Wheel". American journal of pharmaceutical education, 8665. https://doi.org/10.5688/ajpe8665
Olson, Anthony W, et al. "Addressing Hidden Curricula that Subvert the Patient-Centeredness "Hub" of the Pharmacists' Patient Care Process "Wheel"." American journal of pharmaceutical education vol. (2021): 8665. doi: https://doi.org/10.5688/ajpe8665
Olson AW, Isetts BJ, Stratton TP, Vaidyanathan R, Hager KD, Schommer JC. Addressing Hidden Curricula that Subvert the Patient-Centeredness "Hub" of the Pharmacists' Patient Care Process "Wheel". Am J Pharm Educ. 2021 Jul 22;8665. doi: 10.5688/ajpe8665. Epub 2021 Jul 22. PMID: 34301574.
Copy Download .nbib Format: NLM
Phase-Changing Glauber Salt Solution for Medical Applications in the 28-32 °C Interval.

Materials (Basel, Switzerland)

Olson L, Lothian C, Ådén U, Lagercrantz H, Robertson NJ, Setterwall F.
PMID: 34885261
Materials (Basel). 2021 Nov 23;14(23). doi: 10.3390/ma14237106.

(1) Background: The field of medicine requires simple cooling materials. However, there is little knowledge documented about phase change materials (PCM) covering the range of 28 to 40 degrees Celsius, as needed for medical use. Induced mild hypothermia, started...

Cite
Olson L, Lothian C, Ådén U, et al. Phase-Changing Glauber Salt Solution for Medical Applications in the 28-32 °C Interval. Materials (Basel). 2021;14(23)doi: 10.3390/ma14237106.
Olson, L., Lothian, C., Ådén, U., Lagercrantz, H., Robertson, N. J., & Setterwall, F. (2021). Phase-Changing Glauber Salt Solution for Medical Applications in the 28-32 °C Interval. Materials (Basel, Switzerland), 14(23), . https://doi.org/10.3390/ma14237106
Olson, Linus, et al. "Phase-Changing Glauber Salt Solution for Medical Applications in the 28-32 °C Interval." Materials (Basel, Switzerland) vol. 14,23 (2021). doi: https://doi.org/10.3390/ma14237106
Olson L, Lothian C, Ådén U, Lagercrantz H, Robertson NJ, Setterwall F. Phase-Changing Glauber Salt Solution for Medical Applications in the 28-32 °C Interval. Materials (Basel). 2021 Nov 23;14(23). doi: 10.3390/ma14237106. PMID: 34885261; PMCID: PMC8658730.
Copy Download .nbib Format: NLM
Impact of Controlled Storage Conditions on the Hydrolysis and Surface Morphology of Amorphous-UO.

ACS omega

Hanson AB, Schwerdt IJ, Nizinski CA, Lee RN, Mecham NJ, Abbott EC, Heffernan S, Olsen A, Klosterman MR, Martinson S, Brenkmann A, McDonald LW.
PMID: 33817521
ACS Omega. 2021 Mar 16;6(12):8605-8615. doi: 10.1021/acsomega.1c00435. eCollection 2021 Mar 30.

The hydration and morphological effects of amorphous (A)-UO

Cite
Hanson AB, Schwerdt IJ, Nizinski CA, et al. Impact of Controlled Storage Conditions on the Hydrolysis and Surface Morphology of Amorphous-UO. ACS Omega. 2021;6(12):8605-8615doi: 10.1021/acsomega.1c00435.
Hanson, A. B., Schwerdt, I. J., Nizinski, C. A., Lee, R. N., Mecham, N. J., Abbott, E. C., Heffernan, S., Olsen, A., Klosterman, M. R., Martinson, S., Brenkmann, A., & McDonald, L. W. (2021). Impact of Controlled Storage Conditions on the Hydrolysis and Surface Morphology of Amorphous-UO. ACS omega, 6(12), 8605-8615. https://doi.org/10.1021/acsomega.1c00435
Hanson, Alexa B, et al. "Impact of Controlled Storage Conditions on the Hydrolysis and Surface Morphology of Amorphous-UO." ACS omega vol. 6,12 (2021): 8605-8615. doi: https://doi.org/10.1021/acsomega.1c00435
Hanson AB, Schwerdt IJ, Nizinski CA, Lee RN, Mecham NJ, Abbott EC, Heffernan S, Olsen A, Klosterman MR, Martinson S, Brenkmann A, McDonald LW. Impact of Controlled Storage Conditions on the Hydrolysis and Surface Morphology of Amorphous-UO. ACS Omega. 2021 Mar 16;6(12):8605-8615. doi: 10.1021/acsomega.1c00435. eCollection 2021 Mar 30. PMID: 33817521; PMCID: PMC8015116.
Copy Download .nbib Format: NLM
Engaging Underrepresented Minorities in Research: Our Vision for a "Research-Friendly Community".

Sullivan G, Olson M, Cottoms N.
UIID-AD: 3531
2015;595-8. doi: 10.1353/cpr.2015.0073.

This article introduces our "Research-Friendly Community" vision, placing research in the arena of social justice by giving citizens a voice and opportunity to actively determine research agendas in their community. The mission of Tri-County Rural Health Network, a minority-owned,...

Cite
Sullivan G, Olson M, Cottoms N. Engaging Underrepresented Minorities in Research: Our Vision for a "Research-Friendly Community". 2015;595-8doi: 10.1353/cpr.2015.0073.
Sullivan, G., Olson, M., & Cottoms, N. (2015). Engaging Underrepresented Minorities in Research: Our Vision for a "Research-Friendly Community". 595-8. https://doi.org/10.1353/cpr.2015.0073
Sullivan, G, et al. "Engaging Underrepresented Minorities in Research: Our Vision for a "Research-Friendly Community"." vol. (2015): 595-8. doi: https://doi.org/10.1353/cpr.2015.0073
Sullivan G, Olson M, Cottoms N. Engaging Underrepresented Minorities in Research: Our Vision for a "Research-Friendly Community". 2015;595-8. doi: 10.1353/cpr.2015.0073. UIID-AD: 3531.
Copy Download .nbib Format: NLM
Engaging underrepresented minorities in research: Our vision for a “research-friendly community”.

Sullivan G, Olson M, Cottoms N.
UIID-AD: 3725
2015;595-598.

This article introduces our “Research-Friendly Community” vision, placing research in the arena of social justice by giving citizens a voice and opportunity to actively determine research agendas in their community. The mission of Tri-County Rural Health Network, a minority-owned,...

Cite
Sullivan G, Olson M, Cottoms N. Engaging underrepresented minorities in research: Our vision for a “research-friendly community”. 2015;595-598
Sullivan, G., Olson, M., & Cottoms, N. (2015). Engaging underrepresented minorities in research: Our vision for a “research-friendly community”. 595-598.
Sullivan, G, et al. "Engaging underrepresented minorities in research: Our vision for a “research-friendly community”." vol. (2015): 595-598.
Sullivan G, Olson M, Cottoms N. Engaging underrepresented minorities in research: Our vision for a “research-friendly community”. 2015;595-598. UIID-AD: 3725.
Copy Download .nbib Format: NLM
Showing 1177 to 1185 of 1185 entries